AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
284.80
-4.28 (-1.48%)
At close: Oct 21, 2026, 4:00 PM EDT
284.99
+0.19 (0.07%)
After-hours: Oct 21, 2026, 7:56 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
According to 30 analysts polled by S&P Global, AbbVie stock has a consensus rating of "Buy" and an average price target of $282.61. The average 1-year stock price forecast is 0.77% lower than the current stock price, while the lowest is $200 (-29.78%) and the highest is $328 (+15.17%).
Price Target: $282.61 (-0.77%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 17 | 16 | 16 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 8 | 6 | 6 | 5 | 5 | 5 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 32 | 31 | 31 | 31 | 30 | 30 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $300 → $325 | Buy | Maintains | $300 → $325 | +14.12% | Oct 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $303 | Buy | Reiterates | $303 | +6.39% | Oct 20, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $290 | Buy | Reiterates | $290 | +1.83% | Oct 20, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $320 | Buy | Maintains | $320 | +12.36% | Oct 20, 2026 |
| Citi | Citi | Hold Maintains $260 | Hold | Maintains | $260 | -8.71% | Oct 20, 2026 |
Financial Forecast
Revenue This Year
67.62B
from 61.16B
Increased by 10.57%
Revenue Next Year
73.57B
from 67.62B
Increased by 8.79%
EPS This Year
13.96
from 10.00
Increased by 39.61%
EPS Next Year
16.21
from 13.96
Increased by 16.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.